Predictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7.
FST
Insulin-like growth factor-binding protein-7
Precision medicine
RRT
SA-AKI
Tissue inhibitor of metalloproteinases-2
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
13 Jul 2024
13 Jul 2024
Historique:
received:
22
04
2024
accepted:
01
07
2024
medline:
14
7
2024
pubmed:
14
7
2024
entrez:
13
7
2024
Statut:
epublish
Résumé
In sepsis, initial resuscitation with fluids is followed by efforts to achieve a negative fluid balance. However, patients with sepsis-associated acute kidney injury (SA-AKI) often need diuretic or renal replacement therapy (RRT). The dilemma is to predict whether early RRT might be advantageous or diuretics will suffice. Both the Furosemide Stress Test (FST) and measurements of the urinary biomarkers TIMP-2*IGFBP-7, if applied solely, do not provide sufficient guidance. We tested the hypothesis that a combination of two tests, i.e., an upstream FST combined with downstream measurements of urinary TIMP-2*IGFBP-7 concentrations improves the accuracy in predicting RRT necessity. In this prospective, multicenter study 100 patients with sepsis (diagnosed < 48h), AKI stage ≥ 2, and an indication for negative fluid balance were included between 02/2020 and 12/2022. All patients received a standardized FST and urinary biomarkers TIMP-2*IGFBP-7 were serially measured immediately before and up to 12 h after the FST. The primary outcome was the RRT requirement within 7 days after inclusion. 32% (n = 32/99) of SA-AKI patients eventually required RRT within 7 days. With the FST, urine TIMP-2*IGFBP-7 decreased within 2 h from 3.26 ng The combined application of an upstream FST followed by urinary TIMP-2*IGFBP-7 measurements supports highly specific identification of SA-AKI patients requiring RRT. Upcoming interventional trials should elucidate if this high-risk SA-AKI subgroup, identified by our predictive enrichment approach, benefits from an early RRT initiation.
Sections du résumé
BACKGROUND
BACKGROUND
In sepsis, initial resuscitation with fluids is followed by efforts to achieve a negative fluid balance. However, patients with sepsis-associated acute kidney injury (SA-AKI) often need diuretic or renal replacement therapy (RRT). The dilemma is to predict whether early RRT might be advantageous or diuretics will suffice. Both the Furosemide Stress Test (FST) and measurements of the urinary biomarkers TIMP-2*IGFBP-7, if applied solely, do not provide sufficient guidance. We tested the hypothesis that a combination of two tests, i.e., an upstream FST combined with downstream measurements of urinary TIMP-2*IGFBP-7 concentrations improves the accuracy in predicting RRT necessity.
METHODS
METHODS
In this prospective, multicenter study 100 patients with sepsis (diagnosed < 48h), AKI stage ≥ 2, and an indication for negative fluid balance were included between 02/2020 and 12/2022. All patients received a standardized FST and urinary biomarkers TIMP-2*IGFBP-7 were serially measured immediately before and up to 12 h after the FST. The primary outcome was the RRT requirement within 7 days after inclusion.
RESULTS
RESULTS
32% (n = 32/99) of SA-AKI patients eventually required RRT within 7 days. With the FST, urine TIMP-2*IGFBP-7 decreased within 2 h from 3.26 ng
CONCLUSIONS
CONCLUSIONS
The combined application of an upstream FST followed by urinary TIMP-2*IGFBP-7 measurements supports highly specific identification of SA-AKI patients requiring RRT. Upcoming interventional trials should elucidate if this high-risk SA-AKI subgroup, identified by our predictive enrichment approach, benefits from an early RRT initiation.
Identifiants
pubmed: 39002065
doi: 10.1186/s13613-024-01349-4
pii: 10.1186/s13613-024-01349-4
doi:
Types de publication
Journal Article
Langues
eng
Pagination
111Informations de copyright
© 2024. The Author(s).
Références
Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:762–74.
pubmed: 26903335
pmcid: 5433435
doi: 10.1001/jama.2016.0288
Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, Kashani K, Koyner JL, Pannu N, Meersch M, et al. Sepsis-associated acute kidney injury: consensus report of the 28th acute disease quality initiative workgroup. Nat Rev Nephrol. 2023;19:401–17.
pubmed: 36823168
doi: 10.1038/s41581-023-00683-3
Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364: k4891.
pubmed: 30626586
pmcid: 6890472
doi: 10.1136/bmj.k4891
Schuler A, Wulf DA, Lu Y, Iwashyna TJ, Escobar GJ, Shah NH, Liu VX. The impact of acute organ dysfunction on long-term survival in sepsis. Crit Care Med. 2018;46:843–9.
pubmed: 29432349
pmcid: 5953770
doi: 10.1097/CCM.0000000000003023
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49:e1063–143.
pubmed: 34605781
doi: 10.1097/CCM.0000000000005337
Besen BA, Taniguchi LU. Negative fluid balance in sepsis: when and how? Shock. 2017;47:35–40.
pubmed: 27454378
doi: 10.1097/SHK.0000000000000701
Wang Q, Liu F, Tao W, Qian K. Timing of renal replacement therapy in patients with sepsis-associated acute kidney injury: a systematic review and meta-analysis. Aust Crit Care. 2024;37:369–79.
pubmed: 37734999
doi: 10.1016/j.aucc.2023.06.011
Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA. 2016;315:2190–9.
pubmed: 27209269
doi: 10.1001/jama.2016.5828
Investigators S-A, Canadian Critical Care Trials G, Australian, New Zealand Intensive Care Society Clinical Trials G, United Kingdom Critical Care Research G, Canadian Nephrology Trials N, Irish Critical Care Trials G, Bagshaw SM, Wald R, Adhikari NKJ, et al. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383:240–51.
doi: 10.1056/NEJMoa2000741
Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, Lebert C, Bohe J, Badie J, Eraldi JP, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379:1431–42.
pubmed: 30304656
doi: 10.1056/NEJMoa1803213
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375:122–33.
pubmed: 27181456
doi: 10.1056/NEJMoa1603017
Li X, Liu C, Mao Z, Li Q, Zhou F. Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Crit Care. 2021;25:15.
pubmed: 33407756
pmcid: 7789484
doi: 10.1186/s13054-020-03451-y
Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17:R207.
pubmed: 24053972
pmcid: 4057505
doi: 10.1186/cc13015
Chen JJ, Chang CH, Huang YT, Kuo G. Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis. Crit Care. 2020;24:202.
pubmed: 32381019
pmcid: 7206785
doi: 10.1186/s13054-020-02912-8
Rewa OG, Bagshaw SM, Wang X, Wald R, Smith O, Shapiro J, McMahon B, Liu KD, Trevino SA, Chawla LS, et al. The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: a multicenter, prospective, observational study. J Crit Care. 2019;52:109–14.
pubmed: 31035185
pmcid: 8704439
doi: 10.1016/j.jcrc.2019.04.011
Cuartero M, Ballús J, Sabater J, Pérez X, Nin N, Ordonez-Llanos J, Betbesé AJ. Cell-cycle arrest biomarkers in urine to predict acute kidney injury in septic and non-septic critically ill patients. Ann Intensive Care. 2017;7:92.
pubmed: 28884304
pmcid: 5589717
doi: 10.1186/s13613-017-0317-y
Honore PM, Nguyen HB, Gong M, Chawla LS, Bagshaw SM, Artigas A, Shi J, Joannes-Boyau O, Vincent JL, Kellum JA, et al. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med. 2016;44:1851–60.
pubmed: 27355527
pmcid: 5089124
doi: 10.1097/CCM.0000000000001827
Wang W, Shen Q, Zhou X. The predictive value of [TIMP-2]*[IGFBP7] in adverse outcomes for acute kidney injury: a systematic review and meta-analysis. Ren Fail. 2023;45:2253933.
pubmed: 37724518
pmcid: 10512823
doi: 10.1080/0886022X.2023.2253933
Johnson ACM, Zager RA. Mechanisms underlying increased TIMP2 and IGFBP7 urinary excretion in experimental AKI. J Am Soc Nephrol. 2018;29:2157–67.
pubmed: 29980651
pmcid: 6065093
doi: 10.1681/ASN.2018030265
Lumlertgul N, Peerapornratana S, Trakarnvanich T, Pongsittisak W, Surasit K, Chuasuwan A, Tankee P, Tiranathanagul K, Praditpornsilpa K, Tungsanga K, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care. 2018;22:101.
pubmed: 29673370
pmcid: 5909278
doi: 10.1186/s13054-018-2021-1
Nusshag C, Rupp C, Schmitt F, Krautkramer E, Speer C, Kalble F, Tamulyte S, Bruckner T, Zeier M, Reiser J, et al. Cell cycle biomarkers and soluble urokinase-type plasminogen activator receptor for the prediction of sepsis-induced acute kidney injury requiring renal replacement therapy: a prospective, exploratory study. Crit Care Med. 2019;47:e999–1007.
pubmed: 31584458
pmcid: 6867703
doi: 10.1097/CCM.0000000000004042
Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, Joannidis M, Kribben A, Levey AS. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
Sakhuja A, Kumar G, Gupta S, Mittal T, Taneja A, Nanchal RS. Acute kidney injury requiring dialysis in severe sepsis. Am J Respir Crit Care Med. 2015;192:951–7.
pubmed: 26120892
doi: 10.1164/rccm.201502-0329OC
Kolhe NV, Muirhead AW, Wilkes SR, Fluck RJ, Taal MW. National trends in acute kidney injury requiring dialysis in England between 1998 and 2013. Kidney Int. 2015;88:1161–9.
pubmed: 26221750
doi: 10.1038/ki.2015.234
Dusse F, Edayadiyil-Dudasova M, Thielmann M, Wendt D, Kahlert P, Demircioglu E, Jakob H, Schaefer ST, Pilarczyk K. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers. BMC Anesthesiol. 2016;16:76.
pubmed: 27609347
pmcid: 5016985
doi: 10.1186/s12871-016-0244-8
Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, Humphreys BD, Koyner JL, Liu KD, Mour G, et al. Clinical use of the urine biomarker [TIMP-2] x [IGFBP7] for acute kidney injury risk assessment. Am J Kidney Dis. 2016;68:19–28.
pubmed: 26948834
pmcid: 4921267
doi: 10.1053/j.ajkd.2015.12.033
Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.
pubmed: 23388612
pmcid: 4057242
doi: 10.1186/cc12503
Billings FTT, Shaw AD. Clinical trial endpoints in acute kidney injury. Nephron Clin Pract. 2014;127:89–93.
pubmed: 25343828
doi: 10.1159/000363725
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.
pubmed: 3203132
doi: 10.2307/2531595
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.
pubmed: 17569110
doi: 10.1002/sim.2929
Doukas P, Frese JP, Eierhoff T, Hellfritsch G, Raude B, Jacobs MJ, Greiner A, Oberhuber A, Gombert A. The NephroCheck bedside system for detecting stage 3 acute kidney injury after open thoracoabdominal aortic repair. Sci Rep. 2023;13:11096.
pubmed: 37423933
pmcid: 10330159
doi: 10.1038/s41598-023-38242-2
Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, Nerlich M, Schlitt HJ, Kellum JA, Bein T. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS ONE. 2015;10: e0120863.
pubmed: 25798585
pmcid: 4370650
doi: 10.1371/journal.pone.0120863
Fiorentino M, Xu Z, Smith A, Singbartl K, Palevsky PM, Chawla LS, Huang DT, Yealy DM, Angus DC, Kellum JA. Serial measurement of cell-cycle arrest biomarkers [TIMP-2] · [IGFBP7] and risk for progression to death, dialysis, or severe acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2020;202:1262–70.
pubmed: 32584598
pmcid: 7605192
doi: 10.1164/rccm.201906-1197OC
Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Bennett MR, Kimmel PL, et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015;26:2023–31.
pubmed: 25655065
pmcid: 4520172
doi: 10.1681/ASN.2014060535
Clark EG, Bagshaw SM. Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery. Semin Dial. 2015;28:6–11.
pubmed: 25359104
doi: 10.1111/sdi.12300
Lehner GF, Forni LG, Joannidis M. Oliguria and biomarkers of acute kidney injury: star struck lovers or strangers in the night? Nephron. 2016;134:183–90.
pubmed: 27505252
doi: 10.1159/000447979
Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. 2014;29:2054–61.
pubmed: 25237065
pmcid: 4209880
doi: 10.1093/ndt/gfu292
Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Fitzgerald R, Gong MN, Graham DD, Gunnerson K, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014;189:932–9.
pubmed: 24559465
doi: 10.1164/rccm.201401-0077OC
Zhang D, Yuan Y, Guo L, Wang Q. Comparison of urinary TIMP-2 and IGFBP7 cut-offs to predict acute kidney injury in critically ill patients: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2019;98: e16232.
pubmed: 31261582
pmcid: 6617439
doi: 10.1097/MD.0000000000016232
Haerkens MH, Kox M, Lemson J, Houterman S, van der Hoeven JG, Pickkers P. Crew resource management in the intensive care unit: a prospective 3-year cohort study. Acta Anaesthesiol Scand. 2015;59:1319–29.
pubmed: 26079640
pmcid: 5033035
doi: 10.1111/aas.12573
James MT, Bhatt M, Pannu N, Tonelli M. Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol. 2020;16:193–205.
pubmed: 32051567
doi: 10.1038/s41581-019-0247-z
Noble RA, Lucas BJ, Selby NM. Long-term outcomes in patients with acute kidney injury. Clin J Am Soc Nephrol. 2020;15:423–9.
pubmed: 32075806
pmcid: 7057296
doi: 10.2215/CJN.10410919